Response of TT virus to IFN plus ribavirin treatment in patients with chronic hepatitis C | Zendy

Javier Moreno | Zendy; Gloria Moraleda | Zendy; Rafael Bárcena | Zendy; Mluisa Mateos | Zendy; Santos del Campo | Zendy

AI Assistant Blog Pricing

Open Access

Response of TT virus to IFN plus ribavirin treatment in patients with chronic hepatitis C

Author(s) -

Javier Moreno,

Gloria Moraleda,

Rafael Bárcena,

Mluisa Mateos,

Santos del Campo

Publication year - 2004

Publication title -

world journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.427

H-Index - 155

eISSN - 2219-2840

pISSN - 1007-9327

DOI - 10.3748/wjg.v10.i1.143

Subject(s) - ribavirin , viremia , medicine , virology , hepatitis c virus , virus , pegylated interferon , hepatitis c , immunology , gastroenterology

TT virus (TTV) is a newly described DNA virus related to postransfusion hepatitis that produces persistent viremia in the absence of clinical manifestations. PEG-IFN plus ribavirin have been useful in the treatment of chronic hepatitis C infection. This study investigated the responses of TT virus (TTV) and hepatitis C virus (HCV) to PEG-IFN plus ribavirin therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog